Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression

Oncology Reports

Volumn 23, Issue 6, 2010, Pages 1569-1576

  Ma, Yamei ^a   Zhang, Guohua ^a   Fu, Xiangsheng ^a   Xia, Oudong ^a   Zhan, Chunling ^a   Li, Lianjie ^a   Wang, Zhiqing ^a   Wu, Baoping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

IFITM1; LKB1; Peutz Jeghers syndrome; catenin

Indexed keywords

BETA CATENIN; IFITM1 PROTEIN; MESSENGER RNA; PROTEIN; PROTEIN KINASE LKB1; UNCLASSIFIED DRUG; WNT PROTEIN; DIFFERENTIATION ANTIGEN; LEU-13 ANTIGEN; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL LEVEL; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL; ADENOCARCINOMA; ADENOMA; COLON; COLORECTAL TUMOR; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RECTUM; WESTERN BLOTTING; YOUNG ADULT;

ADENOCARCINOMA; ADENOMA; ADOLESCENT; ADULT; AGED; ANTIGENS, DIFFERENTIATION; BETA CATENIN; BLOTTING, WESTERN; COLON; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PEUTZ-JEGHERS SYNDROME; PROTEIN-SERINE-THREONINE KINASES; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 77951761749     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000797     Document Type: Article

References (34)

1. Jansen M, de Leng WW, Baas AF, Myoshi H, Mathus-Vliegen L, Taketo MM, Clevers H, Giardiello FM and Offerhaus GJ: Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut 55: 1-5, 2006.
2. Hemminki A: The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci 55: 735-750, 1999.
3. Van der Weyden L, Jonkers J and Bradley A: Cancer: stuck at first base. Nature 419: 127-128, 2002.
4. Hearle N, Schumacher V, Menko FH, et al: Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12: 3209-3215, 2006.
5. Mehenni H, Resta N, Guanti G, Mota-Vieira L, Lerner A, Peyman M, Chong KA, Aissa L, Ince A, Cosme A, Costanza MC, Rossier C, Radhakrishna U, Burt RW and Picard D: Molecular and clinical characteristics in 46 families affected with Peutz-Jeghers syndrome. Dig Dis Sci 52: 1924-1933, 2007.
6. Boardman LA, Couch FJ, Burgart LJ, Schwartz D, Berry R, McDonnell SK, Schaid DJ, Hartmann LC, Schroeder JJ, Stratakis CA and Thibodeau SN: Genetic heterogeneity in Peutz-Jeghers syndrome. Hum Mutat 16: 23-30, 2000.
7. McGarrity TJ, Kulin HE and Zaino RJ: Peutz-Jeghers syndrome. Am J Gastroenterol 95: 596-604, 2000.
8. McGarrity TJ and Amos C: Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci 63: 2135-2144, 2006.
9. Marignani PA: LKB1, the multitasking tumour suppressor kinase. J Clin Pathol 58: 15-19, 2005.
10. Carretero J, Medina PP, Blanco R, Smit L, Tang M, Roncador G, Maestre L, Conde E, Lopez-Rios F, Clevers HC and Sanchez-Cespedes M: Dysfunctional AMPK activity, signaling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene 26: 1616-1625, 2007.
11. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA and Cantley LC: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 101: 3329-3335, 2004.
12. Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC and Seyfried TN: Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol Cancer 7: 37-52, 2008.
13. Ossipova O, Bardeesy N, DePinho RA and Green JB: LKB1 regulates Wnt signaling in vertebrate development. Nat Cell Biol 5: 889-894, 2003.
14. Giles RH, van Es JH and Clevers H: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653: 1-24, 2003.
15. Clevers H: Wnt breakers in colon cancer. Cancer Cell 5: 5-6, 2004.
16. Fodde R and Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158, 2007.
17. Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, Perret C and Romagnolo B: Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 66: 1949-1955, 2006.
18. Lickert H, Cox B, Wehrle C, Taketo MM, Kemler R and Rossant J: Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos. Development 132: 2599-2609, 2005.
19. Yang Y, Lee JH, Kim KY, Song HK, Kim JK, Yoon SR, Cho D, Song KS, Lee YH and Choi I: The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett 221: 191-200, 2005.
20. Back W, Loff S, Jenne D and Bleyl U: Immunolocalization of beta catenin in intestinal polyps of Peutz-Jeghers and juvenile polyposis syndromes. J Clin Pathol 52: 345-349, 1999.
21. Herter P, Kuhnen C, Müller KM, Wittinghofer A and Müller O: Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps. J Cancer Res Clin Oncol 125: 297-304, 1999.
22. De Leng WW, Westerman AM, Weterman MA, De Rooij FW, Dekken Hv H, De Goeij AF, Gruber SB, Wilson JH, Offerhaus GJ, Giardiello FM and Keller JJ: Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas. Clin Cancer Res 9: 3065-3072, 2003.
23. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M and Offerhaus JA: Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119: 1447-1453, 2000.
24. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, Krush AJ, Yardley JH and Luk GD: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316: 1511-1514, 1987.
25. Ghaffar H, Sahin F, Sanchez-Cepedes M, et al: LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res 9: 2998-3003, 2003.
26. Hatano H, Kudo Y, Ogawa I, Tsunematsu T, Kikuchi A, Abiko Y and Takata T: IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 14: 6097-6105, 2008.
27. Maruyama K, Ochiai A, Akimoto S, Nakamura S, Baba S, Moriya Y and Hirohashi S: Cytoplasmic. beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology 59: 302-309, 2000.
28. Rowan A, Churchman M, Jefferey R, Hanby A, Poulsom R and Tomlinson I: In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol 192: 203-206, 2000.
29. Wei C, Amos CI, Rashid A, Sabripour M, Nations L, McGarrity TJ and Frazier ML: Correlation of staging for LKB1 and Cox-2 in hamartomatous polyps and carcinoma from patients with Peutz-Jeghers syndrome. J Histochem Cytochem 51: 1665-1672, 2003.
30. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, et al: Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 60: 3323-3327, 2000.
31. Anderson CB, Neufeld KL and White RL: Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci USA 99: 8683-8688, 2002.
32. Qiao Q, Ramadani M, Gansauge S, Gansauge F, Leder G and Beger HG: Reduced membranous and ectopic cytoplasmic expression of beta-catenin correlate with cyclin D1 overexpression and poor prognosis in pancreatic cancer. Int J Cancer 95: 194-197, 2001.
33. Kudo Y, Ogawa I, Kitajima S, Kitagawa M, Kawai H, Gaffney PM, Miyauchi M and Takata T: Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66: 6928-6935, 2006.
34. Nezu J, Oku A and Shimane M: Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem Biophys Res Commun 261: 750-755, 1999.